Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
This study has been completed.
Study NCT00050921 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received on December 30, 2002. Last Updated on May 16, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
somatropin
Hepatitis A virus, inactivated
Keyhole-Limpet Hemocyanin
Additional drug interventions recognized in this trial
Anti-HIV Agents
Hormones
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content
